Expertise in
14
conditions

Dr. Michael Pearlman

Neurology
499 E Hampden Ave Ste 360, 
Englewood, CO 
Expertise in
14
conditions
499 E Hampden Ave Ste 360, 
Englewood, CO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Michael Pearlman is a Neurologist in Englewood, Colorado. Dr. Pearlman is highly rated in 14 conditions, according to our data. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

His clinical research consists of co-authoring 5 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Neurology
Licenses
General Practice in TX
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO

Locations

499 E Hampden Ave Ste 360, Englewood, CO 80113

Additional Areas of Focus

Dr. Pearlman has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase II Open-label Study Investigating the Efficacy, Safety and Pharmacokinetic Properties of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma
A Phase II Open-label Study Investigating the Efficacy, Safety and Pharmacokinetic Properties of OKN-007 Combined With Temozolomide in Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: August 12, 2025
Intervention Type: Drug
Study Drugs: OKN-007, Temozolomide (TMZ)
Study Phase: Phase 2
A Multicenter, Open-Label Study With a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme After Failure of Standard First Line Therapy
A Multicenter, Open-Label Study With a Randomized Control Arm of the Efficacy, Safety, and Pharmacokinetics of Intravenously Infused Berubicin in Adult Patients With Recurrent Glioblastoma Multiforme After Failure of Standard First Line Therapy
Enrollment Status: Active_not_recruiting
Publish Date: May 04, 2025
Intervention Type: Drug
Study Drugs: Berubicin, Lomustine
Study Phase: Phase 2
A Phase 1b/2 Study to Assess the Safety, Tolerability and Efficacy of BGB-290 in Combination With Radiation Therapy (RT) and/or Temozolomide (TMZ) in Subjects With First-line or Recurrent/Refractory Glioblastoma
A Phase 1b/2 Study to Assess the Safety, Tolerability and Efficacy of BGB-290 in Combination With Radiation Therapy (RT) and/or Temozolomide (TMZ) in Subjects With First-line or Recurrent/Refractory Glioblastoma
Enrollment Status: Completed
Publish Date: February 04, 2025
Intervention Type: Drug, Radiation
Study Phase: Phase 1/Phase 2
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
A Phase 2/3 Randomized, Open-Label Study of Toca 511, a Retroviral Replicating Vector, Combined With Toca FC Versus Standard of Care in Subjects Undergoing Planned Resection for Recurrent Glioblastoma or Anaplastic Astrocytoma
Enrollment Status: Terminated
Publish Date: February 07, 2020
Intervention Type: Biological, Drug
Study Phase: Phase 2/Phase 3
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
A Phase 3, Randomized, Controlled, Double-Arm, Open-Label, Multi-center Study of VB-111 Combined With Bevacizumab vs. Bevacizumab Monotherapy in Patients With Recurrent Glioblastoma
Enrollment Status: Completed
Publish Date: October 23, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 4 Less Clinical Trials

5 Total Publications

Remission of severe myasthenia gravis after autologous stem cell transplantation.
Remission of severe myasthenia gravis after autologous stem cell transplantation.
Journal: Annals of clinical and translational neurology
Published: June 07, 2023
Similar Doctors
Expertise in
17
conditions
Dr. Kelly G. Knupp
Neurology | Pediatrics | Pediatric Neurology
Expertise in
17
conditions
Dr. Kelly G. Knupp
Neurology | Pediatrics | Pediatric Neurology

University Physicians Incorporated

13123 E 16th Ave, 
Aurora, CO 
 (9.9 miles away)
720-777-1234
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kelly Knupp is a Neurologist and a Pediatrics provider in Aurora, Colorado. Dr. Knupp is highly rated in 17 conditions, according to our data. Her top areas of expertise are West Syndrome, Myoclonic Epilepsy, Spasmus Nutans, and Dravet Syndrome. Dr. Knupp is currently accepting new patients.

Expertise in
17
conditions
Dr. Amanda L. Piquet
Neurology
Expertise in
17
conditions
Dr. Amanda L. Piquet
Neurology

University Physicians Incorporated

1635 Aurora Ct, 
Aurora, CO 
 (9.8 miles away)
720-848-0000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Amanda Piquet is a Neurologist in Aurora, Colorado. Dr. Piquet is highly rated in 17 conditions, according to our data. Her top areas of expertise are Encephalitis, Stiff Person Syndrome, Anti-NMDA Receptor Encephalitis, and Rasmussen Encephalitis. Dr. Piquet is currently accepting new patients.

Expertise in
22
conditions
Dr. Denise Damek
Neurology
Expertise in
22
conditions
Dr. Denise Damek
Neurology

University Physicians Incorporated

13123 E 16th Ave, 
Aurora, CO 
 (9.9 miles away)
720-777-1234
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Denise Damek is a Neurologist in Aurora, Colorado. Dr. Damek is highly rated in 22 conditions, according to our data. Her top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Pearlman's expertise for a condition
ConditionClose
      View All 14 Advanced Conditions
      View All 7 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile